United Orthopedic (UOC) acquired A-Spine Asia for US $20.0MM, merging the company into a UOC subsidiary, with Mr. David Chang serving as A-Spine’s president.
Based in Taiwan, UOC claims the position as the first company in Asia to obtain FDA, CE and CFDA certification for its products, which it sells to >30 countries. The company also claims to hold 20% of the Taiwan spine market. For 2016, UOC recorded revenue of $44.0MM. For the same period, A-Spine reported revenue of $11.3MM.
The acquisition expands UOC’s sales in China, where A-Spine is presently registered. At the end of 2016, UOC established subsidiaries in Europe and Japan, and its Kaohsiung, Taiwan manufacturing facility will be ready for production in 3Q17. UOC’s U.S. subsidiary was established in early 2014.
A-Spine’s portfolio includes the recently-launched full range of Combo® Ti/PEEK Cages configured for ACDF, PLIF, TLIF and P/TLIF. The company completed clinical study of its Redmond® ALIF Ti/PEEK Standalone Cages, investigating the role of titanium in improving the bone-implant interface of PEEK substrates; study results were published in the Journal of Clinical Neuroscience during 4Q15. Ongoing studies continue for Redmond ACDF Ti/PEEK Standalone Cages.
Sources: aspine.com.tw; The Spine Market Group; ORTHOWORLD Inc.
United Orthopedic (UOC) acquired A-Spine Asia for US $20.0MM, merging the company into a UOC subsidiary, with Mr. David Chang serving as A-Spine's president.
Based in Taiwan, UOC claims the position as the first company in Asia to obtain FDA, CE and CFDA certification for its products, which it sells to >30 countries. The company also...
United Orthopedic (UOC) acquired A-Spine Asia for US $20.0MM, merging the company into a UOC subsidiary, with Mr. David Chang serving as A-Spine’s president.
Based in Taiwan, UOC claims the position as the first company in Asia to obtain FDA, CE and CFDA certification for its products, which it sells to >30 countries. The company also claims to hold 20% of the Taiwan spine market. For 2016, UOC recorded revenue of $44.0MM. For the same period, A-Spine reported revenue of $11.3MM.
The acquisition expands UOC’s sales in China, where A-Spine is presently registered. At the end of 2016, UOC established subsidiaries in Europe and Japan, and its Kaohsiung, Taiwan manufacturing facility will be ready for production in 3Q17. UOC’s U.S. subsidiary was established in early 2014.
A-Spine’s portfolio includes the recently-launched full range of Combo® Ti/PEEK Cages configured for ACDF, PLIF, TLIF and P/TLIF. The company completed clinical study of its Redmond® ALIF Ti/PEEK Standalone Cages, investigating the role of titanium in improving the bone-implant interface of PEEK substrates; study results were published in the Journal of Clinical Neuroscience during 4Q15. Ongoing studies continue for Redmond ACDF Ti/PEEK Standalone Cages.
Sources: aspine.com.tw; The Spine Market Group; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
